This announcement is a separate document:
復星醫藥:截至2023年12月31日止年度之年度業績公告
FOSUN PHARMA: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
06:23
The USA Securities and Exchange Commission: morgan stanley smith barney failed to prevent fund abuse.
MS-1.06%
06:22
Oracle expects the adjusted eps for the third fiscal quarter to be between $1.50 and $1.54. The market expects the eps to be $1.57.
ORCL-0.65%
06:20
What signal is released by the return of the mmf policy to 'moderately accommodative'? Expert interpretation.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.